Biodegradable Stents - Global Strategic Business Report

The global market for Biodegradable Stents is estimated at US$3.3 Billion in 2023 and is projected to reach US$27.2 Billion by 2030, growing at a CAGR of 35% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Coronary Artery Stents segment, which is expected to reach US$15.6 Billion by 2030 with a CAGR of 34.8%. The Peripheral Artery Stents segment is also set to grow at 35.2% CAGR over the next 7 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $834.5 Million in 2023, and China, forecasted to grow at an impressive 42.9% CAGR to reach $8.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Biodegradable Stents Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biodegradable Stents Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Biodegradable Stents Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 46 Featured):

Abbott Laboratories
Biotronik SE & Co. KG
Boston Scientific Corporation
Elixir Medical Corporation
Kyoto Medical Planning Co., Ltd.
Sahajanand Medical Technologies Pvt., Ltd.
Terumo Europe NV

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Biodegradable Stents - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World 7-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2024 & 2030
Table 3: World Recent Past, Current & Future Analysis for Coronary Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 4: World 7-Year Perspective for Coronary Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
Table 5: World Recent Past, Current & Future Analysis for Peripheral Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 6: World 7-Year Perspective for Peripheral Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Polymer Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World 7-Year Perspective for Polymer Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
Table 9: World Recent Past, Current & Future Analysis for Metal Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 10: World 7-Year Perspective for Metal Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
Table 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 12: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World 7-Year Perspective for Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
Table 15: World Biodegradable Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 16: USA Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 17: USA 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 18: USA Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 19: USA 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 20: USA Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 21: USA 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

CANADA

Table 22: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 23: Canada 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 24: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 25: Canada 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 26: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 27: Canada 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

JAPAN

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 28: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 29: Japan 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 30: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 31: Japan 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 32: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 33: Japan 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

CHINA

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 34: China Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 35: China 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 36: China Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 37: China 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 38: China Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 39: China 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

EUROPE

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 40: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 41: Europe 7-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2024 & 2030
Table 42: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 43: Europe 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 44: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 45: Europe 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 46: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 47: Europe 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

FRANCE

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 48: France Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 49: France 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 50: France Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 51: France 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 52: France Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 53: France 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

GERMANY

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 54: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 55: Germany 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 56: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 57: Germany 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 58: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 59: Germany 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

ITALY

Table 60: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 61: Italy 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 62: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 63: Italy 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 64: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 65: Italy 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

UNITED KINGDOM

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 66: UK Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 67: UK 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 68: UK Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 69: UK 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 70: UK Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 71: UK 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

SPAIN

Table 72: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 73: Spain 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 74: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 75: Spain 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 76: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 77: Spain 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

RUSSIA

Table 78: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 79: Russia 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 80: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 81: Russia 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 82: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 83: Russia 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

REST OF EUROPE

Table 84: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 85: Rest of Europe 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 86: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 87: Rest of Europe 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 88: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 89: Rest of Europe 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

ASIA-PACIFIC

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 91: Asia-Pacific 7-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2024 & 2030
Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 93: Asia-Pacific 7-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2024 & 2030
Table 94: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 95: Asia-Pacific 7-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2024 & 2030
Table 96: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 97: Asia-Pacific 7-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2024 & 2030

AUSTRALIA

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)

INDIA

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
Biotronik SE & Co. KG
Boston Scientific Corporation
Elixir Medical Corporation
Kyoto Medical Planning Co., Ltd.
Sahajanand Medical Technologies Pvt., Ltd.
Terumo Europe NV

Table Information

Report Attribute	Details
No. of Pages	196
Published	October 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 3.3 Billion
Forecasted Market Value ( USD ) by 2030	$ 27.2 Billion
Compound Annual Growth Rate	35.0%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4721EUR$4,950USD£3,945GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€8969EUR$9,405USD£7,495GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14162EUR$14,850USD£11,835GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 46 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Global Biodegradable Stents Market by Type (Coronary Artery Stents, Non-vascular Stents, Peripheral Artery Stents), Deployment (Balloon-Expandable Stents, Self-Expanding Stents), Material, Design, Application, End User - Forecast 2024-2030

Biodegradable Stents Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

Global Esophageal Stents Market by Type (Biodegradable Stents, Self-expandable Metal Stents, Self-expandable Plastic Stents), Material (Nitinol, Silicone, Stainless Steel), Application, End User - Forecast 2024-2030

Bioresorbable Stents - Global Strategic Business Report

Drug-Eluting Stents - Global Strategic Business Report